Wellness company introduces new CBD products for pets

CV Sciences Launches CBD Chew Line for Pets to Support Wellness in Dogs
CV Sciences, Inc. has made a significant stride in the pet wellness industry with the launch of its CBD chew line for pets. The +PlusCBD™Pet line, which hit the market on March 26, offers chew treats specifically designed to support the wellness of dogs by harnessing the power of cannabidiol (CBD) to address common issues in canines.
As the demand for natural alternatives to support pet wellbeing continues to rise, CV Sciences recognized the opportunity to provide pet parents with a safe and effective option for their furry companions. With many pet owners already using CBD for their own ailments, the company saw a need for a premium CBD chew line that is THC-free and tailored for four-legged friends.
Joseph Dowling, CEO of CV Sciences, expressed his pride in the company’s commitment to quality and safety, stating, “The NASC’s comprehensive safety study further validates CBD supplements to promote the health and wellness of our family pets. Our long-standing commitment to quality and safety will provide pet owners with products they can trust.”
The +PlusCBD™Pet line includes two formulas: Hip and Joint Health Chews and Calming Care Chews. These chews are formulated with CBD derived from organic hemp plants, as well as antioxidants, anti-inflammatory agents, and vital supplements to enhance overall wellbeing in dogs.
Each CBD chew has undergone rigorous testing by independent laboratories to ensure purity, potency, and compliance with industry standards. The Hip and Joint Health Chews target joint pain and discomfort, while the Calming Care Chews aim to promote relaxation in dogs experiencing anxiety and stress.
CV Sciences’ +PlusCBD™Pet line is now available at select retailers across the United States and through the company’s website. Pet parents looking to provide their dogs with natural, effective wellness solutions can now turn to CV Sciences for premium CBD chews that prioritize safety and efficacy.